COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) - Contingent Consideration Liability - Fair Value, Inputs, Level 3 - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Arkis | Other Current Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, Beginning of Period	$ 3,415
Transfers	(3,432)
Gain (loss) from change in fair value of contingent consideration liabilities	17
Balance, End of Period	0
Arkis | Other Long-term Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, Beginning of Period	11,746	$ 14,210
Transfers	3,432
Gain (loss) from change in fair value of contingent consideration liabilities	(402)	(708)
Balance, End of Period	14,776	13,502
Derma Sciences | Other Long-term Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, Beginning of Period	230	230
Gain (loss) from change in fair value of contingent consideration liabilities		0
Balance, End of Period	230	$ 230
ACell | Other Long-term Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, Beginning of Period	0
Additions from acquisition of ACell	23,900
Gain (loss) from change in fair value of contingent consideration liabilities	(400)
Balance, End of Period	$ 23,500